Chee Keng Mok

832 total citations
29 papers, 511 citations indexed

About

Chee Keng Mok is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Chee Keng Mok has authored 29 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Molecular Biology and 12 papers in Infectious Diseases. Recurrent topics in Chee Keng Mok's work include Influenza Virus Research Studies (14 papers), Respiratory viral infections research (7 papers) and RNA and protein synthesis mechanisms (7 papers). Chee Keng Mok is often cited by papers focused on Influenza Virus Research Studies (14 papers), Respiratory viral infections research (7 papers) and RNA and protein synthesis mechanisms (7 papers). Chee Keng Mok collaborates with scholars based in Singapore, Taiwan and United States. Chee Keng Mok's co-authors include Justin Jang Hann Chu, Shin‐Ru Shih, Guang‐Wu Chen, Shih‐Cheng Chang, Chi-Jene Chen, Chiayn Chiang, Jiyi Wang, Bintou Ahmadou Ahidjo, Sai Meng Tham and Regina Ching Hua Lee and has published in prestigious journals such as Nature Communications, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Chee Keng Mok

28 papers receiving 500 citations

Peers

Chee Keng Mok

EPIDE

ACS

IMMUN

Kazuhiko Kanou Japan

Shin‐Ru Shih Taiwan

Kyoko Shiraishi Japan

Elsayed M. Abdelwhab Germany

Dmitriy Pereyaslov Denmark

Yan Feng China

Chris Chan Hong Kong

Mee Kian Poh Singapore

Matthias Opp Netherlands

Kazuhiko Kanou Japan

Chee Keng Mok

169 ×0.6

EPIDE

237 ×1.1

47 ×0.3

ACS

145 ×1.0

77 ×1.4

IMMUN

Citations per year, relative to Chee Keng Mok Chee Keng Mok (= 1×) peers Kazuhiko Kanou

Countries citing papers authored by Chee Keng Mok

Since Specialization

Citations

This map shows the geographic impact of Chee Keng Mok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chee Keng Mok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chee Keng Mok more than expected).

Fields of papers citing papers by Chee Keng Mok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chee Keng Mok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chee Keng Mok. The network helps show where Chee Keng Mok may publish in the future.

Co-authorship network of co-authors of Chee Keng Mok

This figure shows the co-authorship network connecting the top 25 collaborators of Chee Keng Mok. A scholar is included among the top collaborators of Chee Keng Mok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chee Keng Mok. Chee Keng Mok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Siwy Ling, Sainan Wang, Jian Han, et al.. (2025). A conserved long-range RNA interaction in SARS-CoV-2 recruits ADAR1 to enhance virus proliferation. Nature Communications. 16(1). 8460–8460. 1 indexed citations

Keng, Choong Tat, Regina Ching Hua Lee, Bing Shao Chia, et al.. (2023). AAV-CRISPR-Cas13 eliminates human enterovirus and prevents death of infected mice. EBioMedicine. 93. 104682–104682. 15 indexed citations

Wu, Kan Xing, Parveen Kaur, Regina Ching Hua Lee, et al.. (2023). The host-targeting compound peruvoside has a broad-spectrum antiviral activity against positive-sense RNA viruses. Acta Pharmaceutica Sinica B. 13(5). 2039–2055. 9 indexed citations

Mok, Chee Keng, Bintou Ahmadou Ahidjo, Huixin Chen, et al.. (2023). Evaluation of In Vitro and In Vivo Antiviral Activities of Vitamin D for SARS-CoV-2 and Variants. Pharmaceutics. 15(3). 925–925. 11 indexed citations

Mok, Chee Keng, et al.. (2022). Cytopathic Effect (CPE)-Based Drug Screening Assay for SARS-CoV-2. Methods in molecular biology. 2452. 379–391. 4 indexed citations

Mok, Chee Keng, Huixin Chen, Tze Minn Mak, et al.. (2022). Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages. Frontiers in Immunology. 13. 950666–950666. 3 indexed citations

Shan, Sisi, Chee Keng Mok, Shuyuan Zhang, et al.. (2021). A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants. Frontiers in Immunology. 12. 766821–766821. 11 indexed citations

Cross, Gail Brenda, Claire M. Naftalin, Bintou Ahmadou Ahidjo, et al.. (2021). A blood RNA transcriptome signature for COVID-19. BMC Medical Genomics. 14(1). 155–155. 14 indexed citations

Mok, Chee Keng, et al.. (2020). Adenovirus vectored IFN-α protects mice from lethal challenge of Chikungunya virus infection. PLoS neglected tropical diseases. 14(12). e0008910–e0008910. 7 indexed citations

10.

Mok, Chee Keng, et al.. (2020). Establish a standard inactivation protocol for virus research in a high containment laboratory. International Journal of Infectious Diseases. 101. 254–254. 1 indexed citations

11.

Mok, Chee Keng, et al.. (2017). A cross-clade H5N1 influenza A virus neutralizing monoclonal antibody binds to a novel epitope within the vestigial esterase domain of hemagglutinin. Antiviral Research. 144. 299–310. 11 indexed citations

12.

Mok, Chee Keng, Jianping Wu, Qi Zeng, et al.. (2015). A monoclonal antibody binds to threonine 49 in the non-structural 1 protein of influenza A virus and interferes with its ability to modulate viral replication. Antiviral Research. 116. 55–61. 5 indexed citations

13.

Mok, Chee Keng, Shih‐Cheng Chang, Guang‐Wu Chen, et al.. (2014). Pyrosequencing reveals an oseltamivir-resistant marker in the quasispecies of avian influenza A (H7N9) virus. Journal of Microbiology Immunology and Infection. 48(4). 465–469. 12 indexed citations

14.

Kuo, Rei‐Lin, Shu‐Li Yang, Yi‐Chun Liu, et al.. (2014). Influenza A/B virus detection and influenza A virus subtyping with emphasis on the novel H7N9 virus by using multiplex real-time RT-PCR. Journal of Virological Methods. 208. 41–46. 9 indexed citations

15.

Lam, Tommy Tsan‐Yuk, Mǎng Shī, Chung-Chau Hon, et al.. (2013). Systematic phylogenetic analysis of influenza A virus reveals many novel mosaic genome segments. Infection Genetics and Evolution. 18. 367–378. 17 indexed citations

16.

Mok, Chee Keng, Guang‐Wu Chen, Yu‐Nong Gong, et al.. (2013). Evolutionarily conserved residues at an oligomerization interface of the influenza A virus neuraminidase are essential for viral survival. Virology. 447(1-2). 32–44. 2 indexed citations

17.

Lin, Sue‐Jane, Chee Keng Mok, Guang‐Wu Chen, et al.. (2011). Altered Pathogenicity for Seasonal Influenza Virus by Single Reassortment of the RNP Genes Derived From the 2009 Pandemic Influenza Virus. The Journal of Infectious Diseases. 204(6). 864–872. 7 indexed citations

18.

Chen, Guang‐Wu, Shih‐Cheng Chang, Chee Keng Mok, et al.. (2006). Genomic Signatures of Human versus Avian Influenza A Viruses. Emerging infectious diseases. 12(7). 1353–1360. 224 indexed citations

19.

Chang, Shih‐Cheng, Guang‐Wu Chen, Chee Keng Mok, et al.. (2006). Subtyping of Influenza A Isolates in Taiwan—2003 to 2004. Journal of the Formosan Medical Association. 105(11). 895–910. 2 indexed citations

20.

Tsao, Kuo‐Chien, Guang‐Wu Chen, Chung‐Guei Huang, et al.. (2005). False positive antibody results against human T‐cell lymphotropic virus in patients with severe acute respiratory syndrome. Journal of Medical Virology. 77(3). 331–336. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact